论文部分内容阅读
发展疟疾疫苗已经遇到障碍,疟疾正在扩散,特别基金管理机构可能撤出,以下三篇文章评价科学与政府政策上的窘境。一、疟疾研究一下一步该做什么在80年代,分子生物学家试图用新的手段即单克隆抗体和基因重组技术,按照子孢子表膜的结构产生疫苗。为此,一些资助机构倾注数百万美元于疟疾疫苗的研究。然而,临床试验表明新近产生的疫苗无效,这些使美国的国际发展机构(AID)即疫苗研究的最大赞助者极为失望。不仅疫苗规划未能履约而且AID的最高资方屈于内部的斗争,敦促国会指令
There are already obstacles to the development of malaria vaccines, the spread of malaria and the possible withdrawal of the Fund's governing body. The following three articles evaluate the dilemmas of science and government policy. First, the malaria research what to do next step In the 1980s, molecular biologists tried to use new means that monoclonal antibody and gene recombination technology, in accordance with the structure of the sporozoite surface membrane vaccine. To this end, some funding agencies have poured millions of dollars into research on malaria vaccines. However, clinical trials show that the newly generated vaccine is ineffective, which greatly disappoints the U.S. Agency for International Development (AID), the largest sponsor of vaccine research. Not only did the vaccine program fail to meet its obligations but the top employer of AID was bowed to internal struggles, urging Congressional directives